Form 4: AdaptHealth Officer Granted 32,213 Restricted Stock Units

AdaptHealth's Chief Accounting Officer, Christine E. Archbold, was granted 32,213 restricted stock units, increasing her direct beneficial ownership to 107,198 shares.

Summary

• Christine E. Archbold, Chief Accounting Officer of AdaptHealth Corp. (AHCO), acquired 32,213 shares of common stock.
• The acquisition occurred on January 30, 2026, and was reported on February 3, 2026.
• These shares represent restricted stock units (RSUs) granted at a price of $0, which will be settled in common stock upon vesting.
• Following this transaction, Ms. Archbold directly beneficially owns a total of 107,198 shares of AdaptHealth common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, primarily due to the increased alignment of executive interests with shareholder value through equity compensation. It reflects standard corporate governance practices.

Positives

• The grant of restricted stock units aligns the interests of the Chief Accounting Officer with those of shareholders, as the value of her compensation is tied to the company's stock performance.
• The transaction indicates ongoing executive compensation and retention strategies are in place at AdaptHealth.

Negatives

• The shares are restricted stock units, meaning they do not represent immediate liquidity for the officer and are subject to vesting conditions.

Future Outlook

The filing indicates that the acquired restricted stock units will be settled in common stock upon vesting, implying future share issuance contingent on continued employment and/or performance conditions.

Industry Context

StockSavvy.ai notes that restricted stock unit grants are a common form of equity compensation for executives across various industries, including healthcare services, designed to incentivize long-term performance and retention. This grant is consistent with typical executive compensation practices.

Comparison to Industry Standards

• The grant of restricted stock units is a standard practice for executive compensation, comparable to similar grants observed at other publicly traded healthcare providers and medical equipment companies like ResMed Inc. (RMD) or Lincare Holdings Inc. (a subsidiary of Linde plc).
• The $0 acquisition price is typical for RSU grants, reflecting their nature as a compensation award rather than a purchase.

Stakeholder Impact

• Shareholders: The grant of RSUs to a key executive can enhance alignment between management and shareholder interests, potentially leading to better long-term performance.
• Employees (specifically the Chief Accounting Officer): This represents a significant component of the executive's compensation, incentivizing continued service and performance.

Next Steps

• The restricted stock units will vest according to a predetermined schedule, at which point they will be settled in common stock.

Key Dates

Keywords

AdaptHealth, AHCO, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Form 4, Beneficial Ownership, Corporate Governance